Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cardiovascular Stroke

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Cardiovascular Stroke in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Che, D; Chen, J; Hammock, BD; Huang, F; Huang, H; Liu, Y; Qiu, K; Wang, J; Wang, MH; Yang, X1
Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K1
Campbell, WB; Falck, JR; Gross, ER; Gross, GJ; Hsu, AK; Nithipatikom, K; Peart, JN1
Campbell, WB; Endsley, MP; Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K1

Other Studies

4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cardiovascular Stroke

ArticleYear
Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
    Atherosclerosis, 2017, Volume: 263

    Topics: Amidines; Angiogenesis Inducing Agents; Animals; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Drugs, Chinese Herbal; Endothelial Progenitor Cells; Hydroxyeicosatetraenoic Acids; Male; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A

2017
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
    Circulation research, 2004, Oct-15, Volume: 95, Issue:8

    Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones

2004
Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel.
    Journal of molecular and cellular cardiology, 2004, Volume: 37, Issue:6

    Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Male; Mixed Function Oxygenases; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sarcolemma

2004
Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:2

    Topics: Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Female; Hemodynamics; Hydroxyeicosatetraenoic Acids; Ischemic Preconditioning, Myocardial; Male; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones

2006